Hibiki Udagawa

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Hibiki Udagawa

Dec 20, 2024, 14:12 | Science

Yuji Uehara: Resistance to osimertinib in EGFR-mutated LUAD

Yuji Uehara, Medical Oncologist, National Cancer Center, Japan, shared a post on X about a recent…

Oct 16, 2024, 18:00 | Insight

Stephen V Liu: Is immunotherapy effective for HER2 mutant NSCLC?

Stephen V Liu shared on X a recent paper by Yuki Kato et al. titled…

Aug 11, 2024, 08:42 | Insight

Susumu Kobayashi: The importance of BCL-XL during emergence of resistance to EGFR TKIs

Susumu Kobayashi, Associate Professor at Harvard Medical School, shared a post on X about a…

All: 3 Posts: 1 - 100

'

Where to Study to Become ASCO President: 2025 Institutional Rankings

'

Yelak Biru: UK grants first approval for Blenrep in multiple myeloma

'

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

'

Dr. Don Dizon and Dr. Nathan Pennell Reflect on the Evolution of the ASCO Educational Book

'

April is Head and Neck Cancer Awareness Month

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023